Aquestive Therapeutics AQST
NASDAQ AQST
$4.44 -0.19 (-4.10%)
At close: Oct 1, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Other Operating Expenses (2017 - 2026)

Updated

Aquestive Therapeutics' Other Operating Expenses was $972,000 in Q2 2026, down 32.2% from $1.43 million a year earlier and down 0.1% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Other Operating Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aquestive Therapeutics' Other Operating Expenses was $4.81 million through Jun 30, 2026, down 14.3% year-over-year; for FY2025, it was $5.74 million, up 5.1% from FY2024.

  • Other Operating Expenses shows a five-year compound annual growth rate of -15.0% (FY2020 to FY2025).
  • In earlier years, Other Operating Expenses was $5.46 million in FY2024 (+503.2%), $905,000 in FY2023 and $14.99 million in FY2021 (+15.6%).
  • The Q2 2026 figure marks the lowest quarterly Other Operating Expenses since Q4 2023.
  • Compared with a year earlier, Other Operating Expenses was higher in five of the last seven quarters, with growth averaging 1.3%.
  • The best year-over-year quarter for Other Operating Expenses over five years was Q4 2022 (growth of 57.6%); the worst was Q4 2023 (a decline of 82.9%).
  • Per Business Quant data, AQST's Other Operating Expenses in the three quarters before Q2 2026 was $973,000 (Q1 2026), $1.43 million (Q4 2025) and $1.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aquestive Therapeutics 581.12 Mn 121.66 Mn 9.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 972,000.00
Mar 31, 2026 973,000.00
Dec 31, 2025 1.43 Mn
Sep 30, 2025 1.43 Mn
Jun 30, 2025 1.43 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.38 Mn
Sep 30, 2024 1.36 Mn
Jun 30, 2024 1.36 Mn
Mar 31, 2024 1.36 Mn
Dec 31, 2023 905,000.00
Dec 31, 2022 5.31 Mn
Sep 30, 2022 4.63 Mn
Jun 30, 2022 5.24 Mn
Mar 31, 2022 4.21 Mn
Dec 31, 2021 3.37 Mn
Sep 30, 2021 4.40 Mn
Jun 30, 2021 4.47 Mn
Mar 31, 2021 2.76 Mn
Dec 31, 2020 2.79 Mn
API Access

Aquestive Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AQST&period=max&api_key=YOUR_API_KEY